A selective antagonist of mineralocorticoid receptor eplerenone in cardiology practice

被引：0
|
作者：
Gegenava, B. B. [1 ]
Drapkina, O. M. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2015年 / 11卷 / 02期
关键词：
aldosterone; heart failure; atrial fibrillation; chronic renal failure; albuminuria; eplerenone; spironolactone; gynecomastia;
D O I：
10.20996/1819-6446-2015-11-2-177-181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The role of aldosterone in pathophysiological processes is considered. The effects of the selective antagonist of mineralocorticoid receptor eplerenone are analyzed. The advantages of eplerenone compared with spironolactone are discussed.
引用
收藏
页码：177 / 181
页数：5
相关论文
共 50 条
  • [1] Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist
    Takeda, Y
    HYPERTENSION RESEARCH, 2004, 27 (11) : 781 - 789
  • [2] The selective mineralocorticoid receptor antagonist eplerenone prevents decompensation of the liver in cirrhosis
    Schreier, Barbara
    Wolf, Anja
    Hammer, Stefanie
    Pohl, Sabine
    Mildenberger, Sigrid
    Rabe, Sindy
    Gekle, Michael
    Zipprich, Alexander
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (14) : 2956 - 2967
  • [3] The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomerulonephritis
    Zitt, Emanuel
    Eller, Kathrin
    Huber, Julia M.
    Kirsch, Alexander H.
    Tagwerker, Andrea
    Mayer, Gert
    Rosenkranz, Alexander R.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2011, 4 (06): : 606 - 615
  • [4] Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist
    Frances McManus
    Gordon T McInnes
    John MC Connell
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 44 - 52
  • [5] Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist
    McManus, Frances
    McInnes, Gordon T.
    Mc Connell, John
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (01): : 44 - 52
  • [6] Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension
    Takeda, Yoshiyu
    HYPERTENSION RESEARCH, 2009, 32 (05) : 321 - 324
  • [7] Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension
    Yoshiyu Takeda
    Hypertension Research, 2009, 32 : 321 - 324
  • [8] Treatment of Central Serous Retinopathy with the Mineralocorticoid Receptor Antagonist Eplerenone
    Beardsley, Robert
    Montezuma, Sandra
    Johnston, Richard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [9] Effects of the mineralocorticoid receptor antagonist eplerenone in experimental autoimmune encephalomyelitis
    Quintero, Guido S. Alvarez
    Lima, Analia
    Roig, Paulina
    Meyer, Maria
    de Kloet, E. R.
    De Nicola, Alejandro F.
    Garay, Laura I.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 238
  • [10] The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat
    Matono, Tomomitsu
    Koda, Masahiko
    Tokunaga, Shiho
    Sugihara, Takaaki
    Ueki, Masaru
    Murawaki, Yoshikazu
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 25 (06) : 875 - 882
12345